ClinicalTrials.Veeva

Menu

SWEtick - a Prospective Multicenter Study of Tick-borne Diseases in Sweden

A

Anna J Henningsson

Status

Enrolling

Conditions

Tick-Borne Diseases

Study type

Observational

Funder types

Other

Identifiers

NCT06781008
EPM 2022-05330-01

Details and patient eligibility

About

The purpose of the SWEtick project is to increase the knowledge of the various clinical presentations of emerging tick-borne diseases (eTBD), to assess their importance for human health, to develop and validate laboratory methods for diagnosis of eTBD, and to develop recommendations for knowledge-driven management of patients with suspected eTBD within the Swedish healthcare system.

Enrollment

500 estimated patients

Sex

All

Ages

1+ year old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria in TBD and Non-TBD groups:

  • Clinical suspicion of tick-borne disease (physician's assessment based on medical history, symptoms, clinical findings and sometimes laboratory results)

Exclusion Criteria:

  • Incapacitated to understand the study information and make decisions (adults and adolescents >15 years)

Trial design

500 participants in 5 patient groups

TBD
Description:
Patients with confirmed tick-borne disease
Non-TBD
Description:
Patients investigated for suspected tick-borne disease but diagnosed with another condition (tick-borne disease excluded)
Control group CNS
Description:
Patients obtaining spinal anasthesia in conjunction with knee or hip replacement surgery due to arthrosis
Control group arthritis
Description:
Patients with autoinflammatory joint disease
Control group healthy
Description:
Blood donors

Trial contacts and locations

6

Loading...

Central trial contact

Anna J Henningsson, Senior Associate Professor; Johanna Sjöwall, Associate Professor (docent)

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems